The success of the COVID-19 vaccines demonstrated how powerful new technologies based on lipid nanoparticles (LNPs) and messenger ribonucleic acid (mRNA) can be for protecting public health. As more RNA-based medicines are being developed, it is increasingly important that these LNPs are stable and easy to distribute, especially to support global accessibility and improve preparedness […]
Read More